Nitric oxide synthase (NOS) inhibitors have been shown to reduce NO but yie
ld conflicting results on cardiac allograft survival. In this study, we pro
vide an alternative approach specifically to examine the efficacy of a NO s
cavenger on nitrosyl complex formation and graft survival in a model of het
erotopic cardiac transplantation. Efficacy was examined under both acute an
d chronic conditions (i.e., without or with immunosuppression, respectively
). Electron paramagnetic resonance (EPR) spectroscopy of frozen myocardial
tissue from untreated allografts showed progressive increases in nitrosylhe
me and nitrosomyoglobin before graft failure. These signals were not seen i
n either isografts or native hearts of allograft recipients. Both plasma ni
trate plus nitrite and myocardial nitrosyl complex formation in cardiac all
ografts were significantly decreased in recipient animals treated with the
NO scavenger, NOX-100, or by low-dose cyclosporine (CsA). Both intervention
s were nearly equivalent in significantly prolonging graft survival. The sh
ort-term combination treatment of both NOX-100 plus CsA completely eliminat
ed myocardial nitrosyl complex formation and synergistically prolonged graf
t survival. Long-term combination drug treatment (days 0-100) followed by c
essation of therapy resulted in permanent graft acceptance with no evidence
for nitrosyl complex formation. These studies support a role of NO in card
iac allograft rejection. Furthermore, these studies indicate a potential th
erapeutic value of NO scavengers in preventing organ rejection.